ストックスクリーナーアプリを入手
10.46
9.52%
-1.10
アフターアワーズ：
10.56
0.10
+0.96%
Sionna Therapeutics Inc (SION) 最新ニュース
In 2025, biotech IPOs were supposed to bounce back. It hasn't happened yet. - The Business Journals
Sionna Therapeutics (NASDAQ:SION) Reaches New 1-Year Low on Disappointing Earnings - Defense World
Stifel maintains Buy rating on Sionna Therapeutics stock at $32 target - Investing.com Australia
SEC Form 10-K filed by Sionna Therapeutics Inc. - Quantisnow
Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
SIONSionna Therapeutics Latest Stock News & Market Updates - StockTitan
Pre-market Movers: REVB, QSI, EYEN, NAOV ... - RTTNews
Sionna Therapeutics, Inc. (SION): Among Top Insider Purchases Last Month - Insider Monkey
Top 10 Insider Purchases Last Month - Insider Monkey
Sionna Therapeutics, Inc.’s Quiet Period To Expire on March 19th (NASDAQ:SION) - Defense World
February financings slowing, but year outpaces 2022-2023 - BioWorld Online
Guggenheim Initiates Coverage on Sionna Therapeutics (NASDAQ:SION) - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Earns Buy Rating from Analysts at TD Cowen - MarketBeat
Investorideas.com adds New IPOs in Biotech, Technology, Homebuilder, Aerospace, Sports - Investorideas.com newswire
Is Sionna Therapeutics, Inc. (SION) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey
Stifel Nicolaus Initiates Coverage on Sionna Therapeutics (NASDAQ:SION) - Defense World
Sionna Therapeutics (NASDAQ:SION) Coverage Initiated at TD Cowen - Defense World
10 Stocks With At Least $20 Million In Insider Spending Recently - Insider Monkey
Sionna Therapeutics (NASDAQ:SION) Now Covered by Stifel Nicolaus - MarketBeat
TD Cowen Initiates Sionna Therapeutics at Buy -March 04, 2025 at 07:57 am EST - Marketscreener.com
Guggenheim Initiates Sionna Therapeutics at Buy With $45 Price Target -March 04, 2025 at 07:58 am EST - Marketscreener.com
Stifel Initiates Sionna Therapeutics at Buy With $32 Price Target -March 04, 2025 at 07:57 am EST - Marketscreener.com
TD Cowen initiates Sionna Therapeutics stock with Buy rating By Investing.com - Investing.com UK
Goldman Sachs starts Sionna Therapeutics with Early-Stage Biotech designation - TipRanks
Sionna Therapeutics: Promising NBD1 Stabilizers Poised to Challenge Vertex in the $11 Billion CF Market - TipRanks
Sionna Therapeutics: Innovative NBD1 Stabilizers and Strategic Synergies Drive Buy Rating - TipRanks
Guggenheim sets Sionna stock Buy rating, $45 target By Investing.com - Investing.com Canada
Sionna Therapeutics, Inc. (SION): Among Stocks With At Least $10 Million In Insider Spending Recently - Insider Monkey
10 Stocks With At Least $10 Million In Insider Spending Recently - Insider Monkey
Sionna Therapeutics’ NBD1 stabilizers hold potential for cystic fibrosis - The Pharma Letter
Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market - Yahoo Finance
Sionna Therapeutics to Present at the 45th Annual TD Cowen Health Care Conference - The Manila Times
Can This Clinical-Stage CF Treatment Developer Disrupt a $10B+ Market? Key Presentation Coming - Stock Titan
Sionna Therapeutics (SION) Surges in Nasdaq Debut Before Paring Gains - HPBL
Atlas Venture Fund Xi L.P Reports 6.5% Stake In Sionna Therapeutics As Of Feb 10 - Marketscreener.com
The Surprising Stock Insiders Can’t Stop Buying: What’s the Hype? - MotoPaddock
Sionna Therapeutics: The Biotech Stock Insiders Are Snapping Up! - Smartphone Magazine
Sionna Therapeutics: The Under-the-Radar Insider Favorite You’ve Been Missing - Anexartiti
Biopharma Gamble: Why Insiders Are Betting Big on Sionna Therapeutics - DSA
Why Insiders Are Betting Big on Sionna Therapeutics This Year - Bit Perfect Solutions
The Biopharma Gamble: Why Insiders Are Banking on Sionna Therapeutics - Elblog.pl
Is Sionna Therapeutics (SION) Among Stocks Insiders Are Buying This Year? - Insider Monkey
10 Stocks Insiders Are Buying This Year - Insider Monkey
A Buffett Buy, a Biotech IPO, and Other Big Insider Buying - 24/7 Wall St.
Sionna therapeutics sees $20.25 million stock purchase by TPG - MSN
Sionna Therapeutics’ $219.2 Million Upsized IPO - Global Legal Chronicle
Major Stock Acquisition Signals Confidence in Sionna Therapeutics - TipRanks
1.05%
1.79%
大文字化:
|
ボリューム (24 時間):